Pliant Therapeutics PLRX Stock Movement Analysis Breakout Watch 20260418 TMUS beats estimates but TMobile US stock declines despite Q1 2026 earnings beat and 85 revenue growth What Neumora Therapeutics NMRA revealed in previous earnings reports